Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Campos, Eduarda
DOB: 14-DEC-1970 (Age: 54)
Gender: female
Address:
Strepestraat 280
8600 Lampernisse (Belgium)
ID: 4651-576482-0
Report
Date: 05-JUL-2025
Laboratory
dr Ample, Ex
Boulevard du Jardin Botanique 32
1000 Brussels
Requested by
AZ Sint-Jan Brugge-Oostende - Campus Hendrik Serruys
Kaïrostraat 84
8400 Oostende (Belgium)
Specimen
Collected: 04-JUL-2025

Chemistry

Test 04 Jul 2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.8 H 4 - 6 %
Glucose [Mass/volume] in Blood 120.5 H 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 9.8 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.0 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 141.8 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.1 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 109.0 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 28.7 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 224.7 H 130 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 162.3 H 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 137.4 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 54.8 40 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 7.1 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistent hyperglycemia and elevated HbA1c, indicating suboptimal glycemic control. Lipid profile reveals consistently high total cholesterol, LDL, and triglycerides, increasing cardiovascular risk. Renal function and electrolytes are within normal limits, and no significant microalbuminuria is present. Recent stool test for occult blood is at the upper normal limit. Recommend optimization of diabetes and lipid management, and continued monitoring for cardiovascular and renal complications.